Glucose‐6‐phosphate dehydrogenase‐deficient mice have increased renal oxidative stress and increased albuminuria
- 5 October 2009
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 24 (2), 609-616
- https://doi.org/10.1096/fj.09-135731
Abstract
Glucose-6-phosphate dehydrogenase (G6PD) is the rate-limiting enzyme of the pentose phosphate pathway and the principal source of NADPH, a major cellular reductant, and is central to cell survival. Our previous work showed that diabetes and increased aldosterone are acquired forms of G6PD deficiency, leading to decreased G6PD activity and NADPH levels and damage to kidney tissue and endothelial cells. In this study, G6PD-deficient mice were studied to test the hypothesis that decreased G6PD activity per se can cause changes similar to those seen in the acquired conditions of G6PD deficiency. Results show that as compared with control mice, G6PD-deficient mice had increased oxidative stress, as manifested by decreased NADPH levels and decreased GSH levels, and increased markers of lipid peroxidation. G6PD-deficient mice had increased protein kinase C activity, increased nuclear factor-kappaB activity, and increased urinary albumin levels, all of which is similar to changes seen in diabetic mice. Changes persisted as the mice aged, as old G6PD-deficient mice (17-20 mo) had higher urine albumin levels and also had evidence for increased apoptosis in the renal cortex. These results show that decreased G6PD activity per se is sufficient to cause changes similar to those seen in diabetic mice.Keywords
Funding Information
- National Institutes of Health (R01‐DK54380)
This publication has 31 references indexed in Scilit:
- Therapeutic interventions and oxidative stress in diabetesFrontiers in Bioscience-Landmark, 2009
- NAD(P)H Oxidase and Endothelial DysfunctionHormone and Metabolic Research, 2008
- The IκB kinase complex: master regulator of NF-κB signalingImmunologic Research, 2008
- Novel Links between the Long Pentraxin 3, Endothelial Dysfunction, and Albuminuria in Early and Advanced Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2008
- Reactive Oxygen Species, Vascular Oxidative Stress, and Redox Signaling in HypertensionHypertension, 2004
- Glucose-6-phosphate Dehydrogenase Modulates Vascular Endothelial Growth Factor-mediated AngiogenesisOnline Journal of Public Health Informatics, 2003
- Glucose-6-Phosphate Dehydrogenase Overexpression Decreases Endothelial Cell Oxidant Stress and Increases Bioavailable Nitric OxideArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Glucose‐6‐phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailabilityThe FASEB Journal, 2001
- A glucose-6-phosphate dehydrogenase (G6PD) splice site consensus sequence mutation associated with G6PD enzyme deficiencyMutation research. Reviews in mutation research, 1997
- Changes in glutathione peroxidase system and pyridine nucleotide phosphate levels in kidneys of cephaloridine-administered rats.The Japanese Journal of Pharmacology, 1989